The growth of solid tumors depends on the formation of new blood vessels. Since the formation of new vessels in tumors is uncontrolled, it will result in a chaotic and heterogeneous tumor vascularization. Consequently, tumor blood flow is chaotic and variable and leads to irregular metabolic changes, particularly gradients in oxygen (O 2 ), and glucose concentrations. Hypoxia, or a decreased level of O 2 , is therefore a common feature in solid tumors. Even a small proportion of hypoxic cells can have important consequences for tumor progression. First, the effectiveness of radiation therapy is directly dependent on the O 2 tension in the tumor tissue. Second, the effect of certain chemotherapeutic drugs is decreased in hypoxic tumors. Finally, hypoxia may have an impact on the clinical aggressiveness of solid tumors.
As a consequence, significant effort is being made to find reliable methods to assess the tumor oxygenation status. At the moment, the most direct measurement of tumor oxygenation is with polarographic electrodes. A disadvantage of this method is that it is invasive and unable to distinguish between necrotic tissue and viable cells.
Noninvasive imaging of hypoxia utilizing the positron emission tomography (PET) method has received much attention. Nitroimidazoles are compounds that bind to cellular macromolecules under hypoxia, which renders them suitable for imaging of hypoxia when labeled with positron emitting isotopes. 
Comment by Sydney M. Evans
The substance and topic of this thesis, "[ 18 F]FETNIM, Tumor Hypoxia and Positron Emission Tomography," is highly significant because hypoxia is known to be of substantial importance in many aspects of disease in both humans and animals. In terms of cancer, hypoxia has been shown to limit the response of cancer to radiation and chemotherapy, as well as to limit the effectiveness of other therapies such as photodynamic therapy and chemotherapy. Hypoxic tumors have been shown to be biologically more aggressive, with increased incidence of metastasis and invasion. The history of attempts to treat tumor hypoxia has demonstrated that there are substantial intertumoral heterogeneity levels in individual patient tumors. This observation suggests that in order to optimally treat each patient, therapy must be tailored to the individual tumor biology. This has lead to the extreme interest in noninvasive hypoxia imaging.
Positron emission tomography (PET) is an imaging methodology that reports the metabolic function of tissue. There have been extensive studies of the PET hypoxia-marking agent [ 18 F]FMISO in both humans and animals. However, these studies have shown this agent to have limitations, especially because of its unwanted metabolism. Therefore, studies on new agents are immensely important.
This thesis considers [ 18 F]FETNIM based on preliminary data published by DJ Yang, et al. This was a very good decision, both in terms of the importance of the topic and the available information. Because of the problems with the me-
